SuperworthBlack Hawk Acquisition market cap BKHA
Share price times shares outstanding: what the whole company sells for, since 2024.
- Today, Oct 23, 2026
- $22.4M
- Highest close in our data
- $100M
- Oct 2025
Black Hawk Acquisition is worth $22.4M at the close on Oct 23, 2026, at $5.40 a share.
That is down 53% over the last year.
Its highest close in our data was $100M in Oct 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $22.4M | $22.4M | $51.4M | −52% |
| 2025 | $46.7M | $46.5M | $100M | −50% |
| 2024 | $92.6M | $90.3M | $92.7M | n/a |
Against its peers
Companies in Healthcare nearest Black Hawk Acquisition's size, closest first, today.
| Company | Market cap |
|---|---|
| BKHABlack Hawk Acquisition | $22.4M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| ICCCImmucell | $93.1M |
| KEQUKewaunee Scientific | $94.9M |
| PDEXPro DEX | $199.3M |
| PLXProtalix BioTherapeutics | $205.5M |
| NATRNatures Sunshine Products | $213.8M |
| Peer median | $83.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Black Hawk Acquisition
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.